Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Cidara Therapeutics Inc    CDTX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/19/2017 06/20/2017 06/21/2017 06/22/2017 06/23/2017 Date
6.8(c) 6.95(c) 7.25(c) 6.9(c) 6.7(c) Last
137 109 93 098 89 885 178 874 1 034 622 Volume
-0.73% +2.21% +4.32% -4.83% -2.90% Change
More quotes
Financials ($)
Sales 2017 0,83 M
EBIT 2017 -59,2 M
Net income 2017 -59,3 M
Finance 2017 40,0 M
Yield 2017 -
Sales 2018 1,00 M
EBIT 2018 -67,1 M
Net income 2018 -67,5 M
Finance 2018 73,5 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 91,2x
EV / Sales2018 42,5x
Capitalization 116 M
More Financials
Company
Cidara Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of anti-infectives for the treatment of fungal infections.Its portfolio includes CD101 IV, CD101 Topical, and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J.... 
More about the company
Surperformance© ratings of Cidara Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on CIDARA THERAPEUTICS INC
06/23 CIDARA THERAPEUTICS, INC. (NASDAQ : CDTX) Files An 8-K Submission of Matters to ..
06/23 CIDARA THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders ..
06/15 CIDARA THERAPEUTICS : to Participate in the 2017 BIO International Convention
06/09 CIDARA THERAPEUTICS : Joins SAFE-BioPharma Association
05/30 CIDARA THERAPEUTICS : Announces Presentations at ASM Microbe 2017 and the 22nd C..
05/10 CIDARA THERAPEUTICS : reports 1Q loss
05/10 CIDARA THERAPEUTICS, INC. (NASDAQ : CDTX) Files An 8-K Results of Operations and..
05/10 Cidara Provides Corporate Update and Reports First Quarter 2017 Financial Res..
05/10 CIDARA THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIO..
04/25 CIDARA THERAPEUTICS : Announces Promotion of Taylor Sandison, M.D., M.P.H., to C..
More news
Sector news : Bio Therapeutic Drugs
06/23DJOne of the Last Untapped Blockbuster Diseases? Drug Companies Race to Find a ..
06/20 Novartis eye drug works with fewer injections than rival
06/15DJACTELION : J&J Maps Research Plans for Actelion -- WSJ
06/14DJACTELION : Correction to J&J Actelion Story
06/14DJACTELION : J&J Plans to Add Drug Discovery and Early Research to Actelion Unit
More sector news : Bio Therapeutic Drugs
Latest Tweets
06/21Cidara Therapeutics, Inc. $CDTX Stock Rating Upgraded by Zacks Investment Res.. 
06/21Cidara Therapeutics, Inc. $CDTX Cut to “Hold” at Zacks Investment Research  
06/21Cidara Therapeutics downgraded by Zacks Investment Research to hold.  
06/20Cidara Therapeutics upgraded by Zacks Investment Research to buy. $7.75 PT.  
06/16BRIEF-Prosight Management LP reports 5.2 pct passive stake in Cidara Therapeu..
1
More tweets
Qtime:9
News from SeekingAlpha
06/16 HEALTHCARE GAINERS / LOSERS AS OF 11 : 00 am
06/09 INSIDERINSIGHTS.COM DAILY ROUND UP 6 : Arex, opk, cdtx, xene, hdyn,
05/15 SCYNEXIS : Another Buy Opportunity On The Recent Pullback
05/10 Cidara Therapeutics beats by $0.08
05/02 CIDARA : Buy The Run-Up Into Data
Advertisement
Chart CIDARA THERAPEUTICS INC
Duration : Period :
Cidara Therapeutics Inc Technical Analysis Chart | CDTX | US1717571079 | 4-Traders
Full-screen chart
Technical analysis trends CIDARA THERAPEUTI...
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 12,9 $
Spread / Average Target 88%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jeffrey L. Stein President, Chief Executive Officer & Director
Scott M. Rocklage Chairman
Matthew W. Onaitis CFO, Secretary & General Counsel
Taylor Sandison Chief Medical Officer
Theodore R. Schroeder Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CIDARA THERAPEUTICS IN..-30.29%116
AMGEN18.88%127 827
CELGENE CORPORATION15.49%104 381
GILEAD SCIENCES-1.58%92 098
REGENERON PHARMACEUTIC..42.20%55 965
VERTEX PHARMACEUTICALS83.02%33 756
More Results